Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Prostate cancer diagnosis and therapy require targeted delivery systems.
• Magnetic nanoparticles offer potential for imaging and drug delivery.
• Thermo-responsive polymers can enhance nanoparticle functionality.

Purpose of the Study:

• To develop thermo-responsive poly(N-isopropylacrylamide-acrylamide-allylamine)-coated magnetic nanoparticles (PMNPs) conjugated with R11 peptides.
• To evaluate the targeting efficiency and imaging capabilities of R11-conjugated PMNPs (R11-PMNPs) for prostate cancer.
• To assess the in vitro and in vivo performance of R11-PMNPs.

Main Methods:

• Synthesis and characterization of PMNPs with specific size, charge, and thermo-responsive properties.
• Conjugation of R11 peptides to PMNPs for active targeting.
• In vitro studies using prostate cancer cell lines (PC3, LNCaP) and normal cells.
• In vivo biodistribution and magnetic resonance imaging (MRI) studies in tumor-bearing models.

Main Results:

• R11-PMNPs exhibited superparamagnetic behavior and were stable.
• Nanoparticles showed good biocompatibility with normal cells.
• R11-PMNPs demonstrated enhanced uptake by prostate cancer cells compared to unconjugated PMNPs.
• In vivo studies revealed significant accumulation of R11-PMNPs in tumors and improved MRI contrast in tumors.

Conclusions:

• R11-PMNPs are a promising platform for targeted prostate cancer diagnosis and therapy.
• The R11 peptide conjugation enhances nanoparticle targeting to prostate cancer.
• These nanoparticles offer potential for improved imaging and therapeutic outcomes in prostate cancer.